New Jersey Assembly Bill 4550: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

New Jersey · 2026-2027 Regular Session

What it does

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Latest action

Introduced, Referred to Assembly Financial Institutions and Insurance Committee (2026-03-10)

See how A 4550 affects you on CapitolKey

Browse more bills · CapitolKey home